The impact of UK NHS reform could resonate globally on pharma so it's time to prepare for change. pharmaphorum spoke to Mike Sanvoisin, of IMS Health, to hear what's in store.
For the supporting article and to add your comments, please visit http://www.pharmaphorum.com/2011/05/1...
Commenti (0)